Anaphylactic shock to fresh-frozen plasma inactivated with methylene blue

Karine Nubret1, Martine Delhoume, Isabelle Orsel

  • 1Service Anesthésie Réanimation Chirurgicale, Unité d'Hémovigilance, Laboratoire d'Immunologie, Faculté de Médecine, Limoges, France.

Transfusion
|July 30, 2010
PubMed
Abstract

Insights

Methylene blue allergy can cause severe anaphylactic reactions during fresh-frozen plasma (FFP-MB) infusions. These cases highlight potential safety concerns with FFP-MB, particularly in post-cardiac surgery patients.

Area of Science:

  • Anesthesiology and Critical Care Medicine
  • Transfusion Medicine
  • Allergy and Immunology

Background:

  • Methylene blue allergy is a known condition.
  • Virus inactivation using methylene blue in fresh-frozen plasma (FFP-MB) is used in France.
  • FFP-MB has been used for years in Europe.

Observation:

  • Two patients experienced anaphylactic shock during FFP-MB infusion after cardiac surgery.
  • Symptoms included generalized rash.
  • Reactions were managed with epinephrine or extracorporeal circulatory support.

Findings:

  • Allergy was suspected due to timing, lack of other allergens, and rash.
  • Methylene blue allergy was confirmed via skin tests (prick and intradermal) with methylene blue and patent blue.
  • Basophil activation tests further validated the dye's role in the anaphylactic reaction.

Implications:

  • These cases raise questions about the safety of FFP-MB.
  • Further investigation into FFP-MB safety is warranted.
  • Clinicians should be aware of potential methylene blue allergy in FFP-MB transfusions.

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions02:06

Allergic Reactions

Overview
Hypersensitivity Reactions: Cytolytic Reactions01:01

Hypersensitivity Reactions: Cytolytic Reactions

Type II hypersensitivity involves IgG and IgM antibodies targeting cell surface antigens, leading to cell destruction. This can occur through complement activation, antibody-dependent cell-mediated cytotoxicity (ADCC), or acting as opsonins for phagocytosis. When excessive, these reactions cause significant tissue damage.Drug-induced hemolytic anemia is a common example, where drugs like penicillin or cephalosporins bind to red blood cells, forming drug-protein complexes. These complexes...
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...